Smoking Cessation Intervention During Low Dose CT (LDCT) Screening for Lung Cancer

Running, not enrolling · Early Phase 1

Conditions studied: Smoking Cessation

In brief

The goal of this clinical research study is to offer lung cancer screenings to smokers who want to change their smoking behaviors. All eligible participants will receive smoking cessation counseling and may be offered at least one form of smoking cessation drug. Different forms of counseling (the delivery of counseling and access to counseling) will be compared. This is an investigational study. Participants on this study will not be prescribed smoking drugs directly by the study staff. However, participants in this study may or may not receive smoking cessation drugs, depending on what the provider thinks is in the participants best interest. All smoking cessation drugs being used are FDA approved and commercially available. It is investigational to compare the different forms of counseling participants receive. Up to 1260 participants will be enrolled in this study. All will take part at MD Anderson.

Key facts

Study ID
NCT03059940
Run by
M.D. Anderson Cancer Center
People needed
630
Starts
2017-06-16
Expected to finish
2026-06-01
Last updated by the study team
2026-04-15

Who can join

Age: 50 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.